Contingency Management for Attendance - 2

National Institute on Drug Abuse (NIDA)300 enrolled

Overview

The purpose of this study is to evaluate the effectiveness of a low-cost contingency management procedure as compared to standard treatment. Using a cross-over design, CM is implemented at different community-based clinics and compared with non-CM in the same facilities. Research staff collects information regarding patients' demographic characteristics, attendance, and outcomes at the clinics. During Phase A (non-CM), standard clinical practice is in place. During Phase B (CM), all patients have the chance to win prizes by coming to treatment. Each participating clinic is randomly assigned to receive either the A or B phase first; each phase is in effect for 16 weeks.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

300

Conditions

Substance Abuse

Interventions

Rewards valued $1-$100

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Subjects will be patients in treatment at one of the participating clinics during the study period. There are no other inclusion or exclusion criteria because we wish to make enrollment open to increase generalizability.

Locations (1)

University of Connecticut Health Center

Farmington, Connecticut, United States

Outcomes

Primary Outcomes

Drug use

Time frame: baseline and each follow-up

Retention

Time frame: baseline and each follow-up

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.